(Q34124707)

31 July 2017

1 reference

title

Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation (English)

1 reference

31 July 2017

Leo Luznik

1

1 reference

PubMed ID

11965233

31 July 2017

Ephraim J Fuchs

series ordinal

2

1 reference

31 July 2017

1 March 2002

1 reference

31 July 2017

1 reference

31 July 2017

9

1 reference

31 July 2017

2

1 reference

31 July 2017

123-137

1 reference

Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity

31 July 2017

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Use of interferon alfa-2a to treat hematologic relapse of chronic myelogenous leukemia after bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working Parties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Graft-versus-myeloma after donor leukocyte infusion: maintenance of marrow remission but extramedullary relapse with plasmacytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Donor lymphocyte infusion for treatment of life-threatening respiratory syncytial virus infection following bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Feasibility of cellular adoptive immunotherapy for Epstein-Barr virus-associated lymphomas using haploidentical donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Critical role of interleukin-2 in the development of acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Th1 and Th2 subsets: paradigms lost?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-gamma and in interleukin-4-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

The activated type 1-polarized CD8(+) T cell population isolated from an effector site contains cells with flexible cytokine profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

A fail-safe mechanism for maintaining self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Epitope affinity for MHC class I determines helper requirement for CTL priming.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Discrepancy between serological complete remission and concomitant new bone lytic lesions after infusion of escalating low doses of donor lymphocytes in multiple myeloma: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Comparative Outcomes of T-Cell–Depleted and Non–T-Cell–Depleted Allogeneic Bone Marrow Transplantation for Chronic Myelogenous Leukemia: Impact of Donor Lymphocyte Infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327480200900205

10.1177/107327480200900205

21 January 2018

Identifiers

DOI

0 references

PubMed ID

11965233

1 reference

PubMed ID

11965233